NCT00378417View on ClinicalTrials.gov

Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypes

PHASE3CompletedINTERVENTIONAL
Enrollment

3,075

Participants

Timeline

Start Date

March 31, 1995

Study Completion Date

March 31, 1999

Conditions
Otitis MediaPneumococcal Infections
Interventions
BIOLOGICAL

7-valent pneumococcal-CRM197 conjugate vaccine

BIOLOGICAL

7-valent pneumococcal-OMPC conjugate vaccine

Trial Locations (5)

33200

Eteläinen, Keskinen, and Läntinen Study Clinic, Tampere

33500

Itäinen and Pohjoinen Study Clinic, Tampere

33720

Kaakkoinen Study Clinic, Tampere

36200

Kangasala Study Clinic, Kangasala

37101

Nokia Study Clinic, Nokia

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Wyeth-Lederle Vaccines

INDUSTRY

collaborator

Pasteur Merieux Connaught

INDUSTRY

lead

Finnish Institute for Health and Welfare

OTHER_GOV

NCT00378417 - Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypes | Biotech Hunter | Biotech Hunter